Ferozsons Laboratories Ltd 2025 AR2
The report highlights Ferozsons Laboratories Limited's performance and sustainability initiatives for the fiscal year 2025. The company entered into a landmark non-exclusive voluntary license agreement with Gilead Sciences for the manufacture and sale of generic Lenacapavir to treat and prevent HIV in 120 low and lower-middle-income countries. Ferozsons continued its social impact through campaigns like 'Hepatitis Free Pakistan' and 'Stop Diabetes,' and supported education through the National Outreach Programme at LUMS. On International Women's Day 2025, the company launched the 'WILL-CORP' initiative to promote women's leadership and skill development. Additionally, Ferozsons invested in green energy by operating two one-megawatt solar power plants at its Raiwind and Nowshera sites.
Company: Ferozsons Laboratories Ltd
Sector: Health Care
Country: Pakistan
Year: 2025
Type: AR2
Pages: 242
Ferozsons Laboratories Ltd
Annual Report
The report highlights Ferozsons Laboratories Limited's performance and sustainability initiatives for the fiscal year 2025. The company entered into a landmark non-exclusive voluntary license agreement with Gilead Sciences for the manufacture and sale of generic Lenacapavir to treat and prevent HIV in 120 low and lower-middle-income countries. Ferozsons continued its social impact through campaigns like 'Hepatitis Free Pakistan' and 'Stop Diabetes,' and supported education through the National Outreach Programme at LUMS. On International Women's Day 2025, the company launched the 'WILL-CORP' initiative to promote women's leadership and skill development. Additionally, Ferozsons invested in green energy by operating two one-megawatt solar power plants at its Raiwind and Nowshera sites.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jul 1, 2024 - Jun 30, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees